The consistent findings across different methodologies for DOK3 and PAPOLA emphasize their importance in shaping the immune landscape of various cancers, suggesting that these genes could be critical targets for therapeutic interventions to modulate tumor immunity. The gene discussed is PAPOLA; the disease is neoplasm.